192 related articles for article (PubMed ID: 29137864)
1. Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors.
Pingaew R; Mandi P; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2018 Jan; 143():1604-1615. PubMed ID: 29137864
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors.
Leechaisit R; Pingaew R; Prachayasittikul V; Worachartcheewan A; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2019 Oct; 27(19):115040. PubMed ID: 31416738
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
[TBL] [Abstract][Full Text] [Related]
5. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and molecular docking of N,N'-disubstituted thiourea derivatives as novel aromatase inhibitors.
Pingaew R; Prachayasittikul V; Anuwongcharoen N; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2018 Sep; 79():171-178. PubMed ID: 29758407
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives.
Roy PP; Roy K
J Pharm Pharmacol; 2010 Dec; 62(12):1717-28. PubMed ID: 21054398
[TBL] [Abstract][Full Text] [Related]
8. 2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.
Lézé MP; Le Borgne M; Marchand P; Loquet D; Kogler M; Le Baut G; Palusczak A; Hartmann RW
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):549-57. PubMed ID: 15662958
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors.
Di Matteo M; Ammazzalorso A; Andreoli F; Caffa I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Nencioni A; Parenti MD; Soncini D; Del Rio A; Amoroso R
Bioorg Med Chem Lett; 2016 Jul; 26(13):3192-3194. PubMed ID: 27161804
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
Prior AM; Yu X; Park EJ; Kondratyuk TP; Lin Y; Pezzuto JM; Sun D
Bioorg Med Chem Lett; 2017 Dec; 27(24):5393-5399. PubMed ID: 29153737
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 3-(azolylmethyl)-1H-indoles and 3-(alpha-azolylbenzyl)-1H-indoles as selective aromatase inhibitors.
Le Borgne M; Marchand P; Nourrisson MR; Loquet D; Palzer M; Le Baut G; Hartmann RW
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):667-76. PubMed ID: 18035835
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors.
Lézé MP; Le Borgne M; Pinson P; Palusczak A; Duflos M; Le Baut G; Hartmann RW
Bioorg Med Chem Lett; 2006 Mar; 16(5):1134-7. PubMed ID: 16380254
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives.
Wang R; Shi HF; Zhao JF; He YP; Zhang HB; Liu JP
Bioorg Med Chem Lett; 2013 Mar; 23(6):1760-2. PubMed ID: 23403081
[TBL] [Abstract][Full Text] [Related]
16. Discrete Fourier Transform-Based Multivariate Image Analysis: Application to Modeling of Aromatase Inhibitory Activity.
Barigye SJ; Freitas MP; Ausina P; Zancan P; Sola-Penna M; Castillo-Garit JA
ACS Comb Sci; 2018 Feb; 20(2):75-81. PubMed ID: 29297675
[TBL] [Abstract][Full Text] [Related]
17. Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors.
Chamduang C; Pingaew R; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Chem; 2019 Dec; 93():103327. PubMed ID: 31614285
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibition by 2-methyl indole hydrazone derivatives evaluated via molecular docking and in vitro activity studies.
Ozcan-Sezer S; Ince E; Akdemir A; Ceylan ÖÖ; Suzen S; Gurer-Orhan H
Xenobiotica; 2019 May; 49(5):549-556. PubMed ID: 29804490
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation, and molecular docking studies of new pyrazol-3-one derivatives with aromatase inhibition activities.
Yi XJ; El-Idreesy TT; Eldebss TM; Farag AM; Abdulla MM; Hassan SA; Mabkhot YN
Chem Biol Drug Des; 2016 Dec; 88(6):832-843. PubMed ID: 27565954
[TBL] [Abstract][Full Text] [Related]
20. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors.
Roy PP; Roy K
J Mol Model; 2010 Oct; 16(10):1597-616. PubMed ID: 20195667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]